AI-Integrated Wearable Sensor Accurately Measures Step Length for Evaluation of Neurological Diseases
By HospiMedica International staff writers Posted on 16 Jul 2024 |

Step length is recognized as a sensitive and non-invasive metric for assessing a variety of conditions and diseases such as aging, neurological deterioration, neurodegenerative diseases, cognitive decline, and disorders like Alzheimer’s, Parkinson’s, and multiple sclerosis. Traditional devices used to measure step length, including camera-based systems and force-sensitive gait mats, are stationary, bulky, and typically confined to specialized clinics and laboratories. While these methods are accurate, they capture only a momentary glimpse of a person's walking ability, which may not accurately reflect their daily functioning. Daily walking patterns can vary with changes in a person’s fatigue, mood, and medication use. To address these limitations, researchers have developed a machine learning-based interdisciplinary model that accurately estimates step length and can be integrated into a wearable device attached to the lower back with tape, facilitating continuous step monitoring in everyday settings.
Researchers at Tel Aviv University (TAU, Tel Aviv, Israel) and Ichilov’s Tel Aviv Sourasky Medical Center overcame the limitations of existing step length measurement devices by utilizing IMU (inertial measurement unit) systems. These lightweight and relatively inexpensive sensors are already embedded in every smartphone and smartwatch and can measure walking-related parameters. Previous investigations into IMU-based wearable devices for step length assessment were conducted solely on healthy individuals without walking impairments, relied on small sample sizes that prevented generalization, and involved devices that were uncomfortable and often required multiple sensors. The goal was to create an effective, user-friendly solution suitable for individuals with mobility issues, including the elderly and those with medical conditions, enabling continuous, day-long data collection on step length within the patient's usual environment.
In an article describing the research published on May 25, 2024, in the journal Digital Medicine, the team utilized IMU sensor-based gait data along with step length measurements previously gathered in a conventional setting from 472 individuals with various conditions, including Parkinson’s disease, mild cognitive impairment, healthy elderly individuals, younger healthy adults, and people with multiple sclerosis. A substantial and varied dataset of 83,569 steps was compiled from these participants. The researchers employed this dataset to train several machine learning models that convert IMU sensor data into accurate step length estimates. To assess the models’ effectiveness, they tested how well these models could generalize by evaluating their ability to accurately analyze new data not previously used in training, demonstrating the models' robustness in real-world settings.
“We found that the model called XGBoost is the most accurate and is 3.5 times more accurate than the most advanced biomechanical model currently used to estimate step length,” said Assaf Zadka, a graduate student in the Department of Biomedical Engineering at TAU, who led the research. “For a single step, the average error of our model was 6 cm, compared to 21 cm predicted by the conventional model. When we evaluated an average of 10 steps, we arrived at an error of less than 5 cm, a threshold known in the professional literature as ‘the minimum difference that has clinical importance,’ which allows identifying a significant improvement or decrease in the subject’s condition. In other words, our model is robust and reliable, and can be used to analyze sensor data from subjects, some with walking difficulties, who were not included in the original training set.”
Related Links:
Tel Aviv University
Tel Aviv Sourasky Medical Center
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more